Calcium, Vitamin D Supplements May Reduce Cancer Mortality in Long Term
MONDAY, March 11, 2024 -- For postmenopausal women, calcium and vitamin D (CaD) supplements may reduce cancer mortality and increase cardiovascular disease (CVD) mortality after more than 20 years of follow-up, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2024 Category: Pharmaceuticals Source Type: news
Wegovy is no longer just a weight-loss drug
Novo Nordisk, the Danish drug maker whose fortunes have soared on the popularity of its GLP-1 agonist drugs, scored a long-sought label expansion for its weight-loss drug Wegovy on Friday, with FDA approving it to reduce the risk of major cardiovascular events in adults who are obese or overweight…#novonordisk #danish #glp1 #fda #obese #elililly #novo #denmark #novoholdings #catalent (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news
Serious Issues With Slow Heartbeat Flagged for Afib Patients on Antiarrhythmics
(MedPage Today) -- Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study.
Afib patients prescribed antiarrhythmic drugs (AADs) had several-fold... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 11, 2024 Category: Cardiology Source Type: news
Nurse-Led Strategy Reduces Cardiovascular Risk Factors for People With HIV
MONDAY, March 11, 2024 -- Nurse-led management can lower cardiovascular risk factors among individuals with HIV receiving antiretroviral therapy, according to a study published online March 5 in JAMA Network Open.
Christopher T. Longenecker,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2024 Category: Pharmaceuticals Source Type: news
How Does Snoring Affect Cardiovascular Health? How Does Snoring Affect Cardiovascular Health?
Most patients with obstructive sleep apnea, which has been hypothesized as modifiable risk factor for cardiovascular disease, snore loudly every night.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 11, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Which Factors Affect Stroke Recurrence After Chagas Disease? Which Factors Affect Stroke Recurrence After Chagas Disease?
A recent study found that cardiovascular risk factors were prevalent among patients with Chagas disease.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 11, 2024 Category: Allergy & Immunology Tags: Cardiology Source Type: news
Higher Dietary Niacin Tied to Lower Mortality Risk in MASLD Higher Dietary Niacin Tied to Lower Mortality Risk in MASLD
The analysis of NHANES data found no evidence of an inverse association between dietary niacin intake and the risk for cardiovascular disease mortality.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 11, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
Expert's 'do not eat' warning as popular breakfast could send cholesterol skyrocketing
Saturated fats found in a buttery breakfast food could raise your "bad" cholesterol, putting your cardiovascular health at risk. (Source: Daily Express - Health)
Source: Daily Express - Health - March 9, 2024 Category: Consumer Health News Source Type: news
FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are…#fda #novonordisk #wegovy #johnsharretts #marthagulati #ozempic #medicare #tricianeuman #kff #ahip (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
Use of CGM Linked to Lower Risk of Retinopathy in Type 1 Diabetes
(MedPage Today) -- In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and proliferative diabetic retinopathy... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 9, 2024 Category: Cardiology Source Type: news
FDA clears Wegovy manufacturer to market weight-loss drug for heart health
The Food and Drug Administration on Friday approved Wegovy manufacturer Novo Nordisk ' s application to add cardiovascular benefits to the weight-loss drug ' s label. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 8, 2024 Category: Consumer Health News Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
FRIDAY, March 8, 2024 -- The U.S. Food and Drug Administration has approved Wegovy (semaglutide) for the prevention of myocardial infarction, stroke, and cardiovascular death in patients with obesity or overweight.
In one multinational study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2024 Category: Pharmaceuticals Source Type: news
FDA Approves Semaglutide for Cardiovascular Risk Reduction FDA Approves Semaglutide for Cardiovascular Risk Reduction
Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 8, 2024 Category: Cardiology Tags: Diabetes & Endocrinology Source Type: news
Wegovy Approved in the US for Cardiovascular Risk Reduction in People with Overweight or Obesity and Established Cardiovascular Disease
Bagsværd, Denmark, 8 March 2024– Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a supplemental New Drug Application (sNDA) for the indication of reducing... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 8, 2024 Category: Drugs & Pharmacology Source Type: news
